[ Myron, Hyal Pharm. ]
Sounds pretty cool to me. Here are their U.S. patents, some of which sound damn relevant at first blush.......
5674857
Use of hyaluronic acid to repair ischemia reperfusion damage
80%
5639738
Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
80%
5614506
Use of hyaluronic acid and forms to prevent arterial restenosis
80%
5079236
Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of
use
80%
5077296
Method for treating equine navicular disease with pentoxifylline, and composition containing
pentoxifylline for administrating to horses
80%
5039521
Immune cell proliferation inhibitors
From the recent quarterly...... "31,703,780 common shares and US$4.9 million in debentures outstanding at April 17, 1998 and cash of $9.4 million (US $6.6 million) at March 31, 1998". I don't see anything scary there, but they will need funding ('97 burn was C$19 million) soon.
Eva Turley, their V.P. R&D, is a very respected scientist.
You'd want to know the skivvy on why the two directors "resigned" in March. Looks like it may be a find, but...... I'm a little distressed by the reference to an AK market of $240 million when they're talking a topical analgesic....
a quick $0.02..... take it for what it's worth.
Rick
|
